Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,43 € ↓ -0,01 (-0,01%)
2026-06-04
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionColony Group, LLC
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Colony Group, LLC closes position in BRM / Bristol-Myers Squibb Company

On May 14, 2026 - Colony Group, LLC filed a 13F-HR form disclosing ownership of 0 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 558,701 shares of Bristol-Myers Squibb Company. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 0 -558,701 -100.00 0 -100.00
2026-02-13 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 558,701 339,041 154.35 30,080 203.40 0.0343
2025-11-14 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 219,660 12,029 5.79 9,914 3.15 0.0160
2025-08-14 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 207,631 -10,455 -4.79 9,611 -27.74 0.0208
2025-05-20 2025-03-31 13F/A-1 BRISTOL-MYERS SQUIBB COM 110122108 218,086 -8,352 -3.69 13,301 3.86 0.0333
2025-05-15 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 218,086 516 13,301 0.0333
2025-05-29 2024-12-31 13F/A-2 BRISTOL-MYERS SQUIBB COM 110122108 226,438 43,334 23.67 12,807 35.19 0.0333
2025-05-20 2024-12-31 13F/A-1 BRISTOL-MYERS SQUIBB COM 110122108 217,570 34,466 12,807 0.0333
2025-02-14 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 217,570 34,466 12,807 0.0333
2024-11-14 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 183,104 -98,888 -35.07 9,474 86,018.18 0.0302
2024-08-15 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 281,992 74,471 35.89 12 0.00 0.0394
2024-05-16 2024-03-31 13F BRISTOL MYERS SQUIBB Common 110122108 207,521 -1,290 -0.62 11 10.00 0.0914
2024-02-15 2023-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 208,811 208,811 11 0.1404
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.